fda warning letters compounded semaglutide 2025 september Hims is in the crosshairs. What does it mean for compounding? FDA issued 25 warning letters

Healthcare providers should consider both the volume of insulin and the injection site when recommending needle sizes

Hamilelik ve emzirme dnemindeki kadnlarda, semaglutide'in anne ve bebek zerindeki etkileri netlemediinden kullanlmamaldr

[5] Perioperative considerations: Delayed gastric emptying has emerged as a significant concern in the perioperative setting

Food and Drug Administration (FDA) currently accepts two histological endpoints for accelerated approval: (1) resolution of MASH without worsening of fibrosis, and (2) improvement in fibrosis by at least one stage without worsening of MASH [96]

T., Moncada, M., de Medeiros, F., & Gabriny, L

Participants with diabetes saw morning glucose readings decline from diabetic ranges into levels approaching normal